Cleveland, OHNCT07016620Now EnrollingIRB Ready

Benign Prostatic Hyperplasia (BPH) Clinical Trial in Cleveland, OH

Access cutting-edge benign prostatic hyperplasia (bph) treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.

Sponsored by The Cleveland Clinic

Quick Self-Assessment

See if you qualify for this Cleveland location

Preparing your pre-screening questions…

Expert Care in Cleveland

Access benign prostatic hyperplasia (bph) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related benign prostatic hyperplasia (bph) treatment provided free

Apply for This Cleveland Location

Check if you qualify for this benign prostatic hyperplasia (bph) clinical trial in Cleveland, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cleveland

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cleveland site if eligible
  4. 4Begin participation

About This Benign Prostatic Hyperplasia (BPH) Study in Cleveland

Benign prostatic hyperplasia (BPH) is a common condition affecting aging men, often leading to lower urinary tract symptoms (LUTS). While Minimally Invasive Surgical Therapies (MIST) procedures offer less invasive alternatives to traditional surgery, some patients experience symptom recurrence or require further intervention due to lack of adequate relief of obstruction. Treatment of persistent obstruction after MIST therapy (BPH salvage therapy) typically requires surgical intervention like transurethral resection of prostate (TURP). This study proposes to evaluate the effectiveness of in-office transperineal laser ablation (TPLA) using the Echolaser system as a minimally invasive treatment option for these patients, potentially avoiding more invasive surgical procedures. The Cleveland Clinic sees a high volume of BPH salvage patients, making this an ideal setting for this research.

Sponsor: The Cleveland Clinic

Who Can Participate

Inclusion Criteria

Men \> 40 years old
History of Minimally invasive BPH procedure within the last 5 years.
IPSS \>= 12
Prostate Volume 30 - 80 gr as assessed by CT, MRI or TRUS.
PSA \<4 or for patients with PSA 4-10 evaluation has been performed to rule out prostate cancer using biopsy, MRI, biomarker, or surgeon judgement. Labs within 1 year of study initiation
PVR \> 150cc or reduced flow on uroflow likely due to obstruction based on clinical judgement
IIEF-6\>or =10 without medication

Exclusion Criteria

Indwelling catheter or intermittent catheterization
History of urethral strictures
Previous diagnosis of Prostate cancer
Active UTI or prostatitis
Hypoactive detrusor function
Neurogenic bladder (secondary to stroke, Multiple Sclerosis, Parkinson's disease, Spinal cord injury)
Ejaculatory dysfunction (retrograde ejaculation, anorgasmia or anejaculation)
Prior traditional BPH surgery (TURP, PVP, Aquablation, HOLEP, SP)
Presence of obstructive median lobe
Moderate to severe or severe ED based on IIEF-6/SHIM (SHIM of 10)
Peyronie's disease

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cleveland?

Yes, this clinical trial (NCT07016620) has an active research site in Cleveland, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Benign Prostatic Hyperplasia (BPH) Treatment Options in Cleveland, OH

If you're searching for benign prostatic hyperplasia (bph) treatment options in Cleveland, OH, this clinical trial (NCT07016620) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced benign prostatic hyperplasia (bph) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all benign prostatic hyperplasia (bph) clinical trials near you to find additional studies recruiting in your area.

Ready to Join in Cleveland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cleveland, OH